A recent report from the Office of the Utah State Auditor revealed that the Department of Health and Human Services (DHHS) ...

FDA has requested the HOPE-3 clinical study report (CSR) as part of the BLA review processCompany expects to submit updates to the BLA in ...

There is a good reason for health insurers to occasionally require prior authorization for medical treatment. If a doctor ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

The NRC has issued a Federal Register notice confirming the January 8, 2026 effective date of its direct final rule ...

With 2026 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care ...

Explore the importance of timing when taking bipolar medications to maximize effectiveness and minimize side effects. Learn ...

The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With ...

The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients.

The FDA commissioner's effort to shorten the review of drugs favored by the Trump administration is causing alarm across the ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...